Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

anti-OX40 agonist monoclonal antibody ABBV-368

An agonistic humanized IgG1 monoclonal antibody that recognizes the co-stimulatory receptor OX40 (CD134; tumor necrosis factor receptor superfamily member 4; TNFRSF4), with potential immunostimulatory activity. Upon administration, anti-OX40 agonist monoclonal antibody ABBV-368 selectively binds to and activates OX40. This may induce the proliferation of memory and effector T-lymphocytes and inhibit the function of T-regulatory cells (Tregs) in the tumor microenvironment (TME). OX40, a cell surface glycoprotein and member of the tumor necrosis factor receptor superfamily (TNFRSF), is expressed on T lymphocytes and plays an essential role in T-cell activation and differentiation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:agonistic anti-OX40 monoclonal antibody ABBV-368
anti-OX40 agonistic monoclonal antibody ABBV-368
Code name:ABBV 368
ABBV-368
ABBV368
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search